Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration

被引:30
作者
Miyazawa, Haruna [1 ,2 ]
Honda, Tomoyuki [1 ,2 ]
Miyauchi, Sayuri [1 ,2 ]
Domon, Hisanori [1 ]
Okui, Takafumi [1 ,2 ]
Nakajima, Takako [1 ,3 ]
Tabeta, Koichi [1 ]
Yamazaki, Kazuhisa [1 ,2 ]
机构
[1] Niigata Univ, Ctr Transdisciplinary Res, Chuo Ku, Niigata 9518514, Japan
[2] Niigata Univ, Lab Periodontol & Immunol, Div Oral Sci Hlth Promot, Grad Sch Med & Dent Sci,Chuo Ku, Niigata 9518514, Japan
[3] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Chuo Ku, Niigata 9518514, Japan
基金
日本学术振兴会;
关键词
PCSK9; LDL cholesterol; Periodontitis; Chronic inflammation; CORONARY-HEART-DISEASE; LIPOPROTEIN RECEPTOR GENE; INFLAMMATORY MARKERS; PROTEIN; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; TRANSCRIPTION; MECHANISMS; CELLS; RISK;
D O I
10.1016/j.cca.2011.09.023
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Periodontal disease increases the risk of atherothrombotic disease, and high concentrations of low density lipoprotein (LDL) cholesterol are considered to be involved: however, the underlying mechanisms are largely unknown. Recent studies demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a critical role in circulating LDL cholesterol concentrations. The aim of the present study is to analyze serum PCSK9 concentrations and their relation to lipoprotein concentrations in periodontitis patients. Methods: Sera were obtained from 40 periodontitis patients and 30 control subjects. PCSK9 concentrations, high-sensitivity C-reactive protein (hs-CRP), IL-6, TNF-alpha and Porphyromonas gingivalis antibodies were measured by ELISA, and lipid profiles were determined by a commercial laboratory. Results: Periodontitis patients demonstrated significantly higher serum antibody titer to P. gingivalis and hs-CRP concentrations than control subjects, suggesting infection with P. gingivalis and a systemic inflammatory response. PCSK9 concentrations in periodontitis patients were significantly higher than those in control subjects. However, the concentrations of total and LDL cholesterols were not significantly different between periodontitis patients and control subjects. Moreover, no correlations were observed between PCSK9 concentrations and lipid profiles. Conclusion: Periodontal infection upregulates PCSK9 production. However, further studies are required to elucidate how periodontal infection affects PCSK9 concentrations and subsequent lipid metabolism. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 159
页数:6
相关论文
共 50 条
  • [21] Exercise training increased gene expression of LDL-R and PCSK9 in intestine: link to transintestinal cholesterol excretion
    Farahnak, Zahra
    Chapados, Natalie
    Lavoie, Jean-Marc
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2018, 37 (03) : 309 - 317
  • [22] Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease
    Zimetti, Francesca
    Caffarra, Paolo
    Ronda, Nicoletta
    Favari, Elda
    Adorni, Maria Pia
    Zanotti, Ilaria
    Bernini, Franco
    Barocco, Federica
    Spallazzi, Marco
    Galimberti, Daniela
    Ricci, Chiara
    Ruscica, Massimiliano
    Corsini, Alberto
    Ferri, Nicola
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (01) : 315 - 320
  • [23] How far down to push the LDL cholesterol? PCSK9 where statins fail
    Simko, V
    Ginter, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (04): : 193 - 194
  • [24] New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol
    Meng, Fan-Hua
    Liu, Shuai
    Xiao, Jian
    Zhou, Yu-Xia
    Dong, Le-Wei
    Li, Yun-Feng
    Zhang, Yan-Qing
    Li, Wei-Hui
    Wang, Ju-Qiong
    Wang, Yan
    Song, Bao-Liang
    Ma, Yi-Tong
    Fu, Zhen-Yan
    Luo, Jie
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (07) : 1219 - 1233
  • [25] The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy
    Feng, Q.
    Wei, W. Q.
    Chung, C. P.
    Levinson, R. T.
    Bastarache, L.
    Denny, J. C.
    Stein, C. M.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (02) : 204 - 208
  • [26] The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis
    Davignon, Jean
    Dubuc, Genevieve
    Seidah, Nabil G.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (05) : 308 - 315
  • [27] The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis
    Jean Davignon
    Geneviève Dubuc
    Nabil G. Seidah
    Current Atherosclerosis Reports, 2010, 12 : 308 - 315
  • [28] PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates
    Lindholm, Marie W.
    Elmen, Joacim
    Fisker, Niels
    Hansen, Henrik F.
    Persson, Robert
    Moller, Marianne R.
    Rosenbohm, Christoph
    Orum, Henrik
    Straarup, Ellen M.
    Koch, Troels
    MOLECULAR THERAPY, 2012, 20 (02) : 376 - 381
  • [29] Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population
    Cui, Qin
    Ju, Xianxia
    Yang, Tao
    Zhang, Mei
    Tang, Wei
    Chen, Qi
    Hu, Yong
    Haas, Joseph V.
    Troutt, Jason S.
    Pickard, Richard T.
    Darling, Ryan
    Konrad, Robert J.
    Zhou, Hongwen
    Cao, Guoqing
    ATHEROSCLEROSIS, 2010, 213 (02) : 632 - 636
  • [30] How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors
    Cybulska, Barbara
    Klosiewicz-Latoszek, Longina
    Penson, Peter E.
    Nabavi, Seyed Mohammad
    Lavie, Carl J.
    Banach, Maciej
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 67 : 65 - 74